Literature DB >> 12461567

Regulation of B-cell fate by antigen-receptor signals.

Hiroaki Niiro1, Edward A Clark.   

Abstract

Recent evidence indicates that B cells are instructed continuously by B-cell receptor (BCR) signals to make crucial cell-fate decisions at several checkpoints during their development. Targeted disruption of BCR signalling components leads to distinct blocks in B-cell maturation, which indicates that key kinases and adaptors fine-tune BCR signalling to direct appropriate cell fates. Recent progress in unravelling the molecular mechanisms of the BCR signalling pathways has helped to clarify how BCR signals regulate the proliferation, survival and apoptosis of developing B cells.

Mesh:

Substances:

Year:  2002        PMID: 12461567     DOI: 10.1038/nri955

Source DB:  PubMed          Journal:  Nat Rev Immunol        ISSN: 1474-1733            Impact factor:   53.106


  205 in total

1.  Antibodies specific for a segment of human membrane IgE deplete IgE-producing B cells in humanized mice.

Authors:  Hans D Brightbill; Surinder Jeet; Zhonghua Lin; Donghong Yan; Meijuan Zhou; Martha Tan; Allen Nguyen; Sherry Yeh; Donnie Delarosa; Steven R Leong; Terence Wong; Yvonne Chen; Mark Ultsch; Elizabeth Luis; Sree Ranjani Ramani; Janet Jackman; Lino Gonzalez; Mark S Dennis; Anan Chuntharapai; Laura DeForge; Y Gloria Meng; Min Xu; Charles Eigenbrot; Wyne P Lee; Canio J Refino; Mercedesz Balazs; Lawren C Wu
Journal:  J Clin Invest       Date:  2010-05-10       Impact factor: 14.808

2.  N-Glycan Branching Is Required for Development of Mature B Cells.

Authors:  Christie-Lynn Mortales; Sung-Uk Lee; Michael Demetriou
Journal:  J Immunol       Date:  2020-06-26       Impact factor: 5.422

3.  The cytokine midkine and its receptor RPTPζ regulate B cell survival in a pathway induced by CD74.

Authors:  Sivan Cohen; Or-yam Shoshana; Einat Zelman-Toister; Nitsan Maharshak; Inbal Binsky-Ehrenreich; Maya Gordin; Inbal Hazan-Halevy; Yair Herishanu; Lev Shvidel; Michal Haran; Lin Leng; Richard Bucala; Sheila Harroch; Idit Shachar
Journal:  J Immunol       Date:  2011-12-02       Impact factor: 5.422

4.  Redirection of B cell responsiveness by transforming growth factor beta receptor.

Authors:  Jurgen Roes; B Ken Choi; Balthazar B Cazac
Journal:  Proc Natl Acad Sci U S A       Date:  2003-05-28       Impact factor: 11.205

5.  Activation of RasGRP3 by phosphorylation of Thr-133 is required for B cell receptor-mediated Ras activation.

Authors:  Yuichi Aiba; Masatsugu Oh-hora; Shigeki Kiyonaka; Yayoi Kimura; Atsushi Hijikata; Yasuo Mori; Tomohiro Kurosaki
Journal:  Proc Natl Acad Sci U S A       Date:  2004-11-15       Impact factor: 11.205

Review 6.  Toll-like receptors and B-cell receptors synergize to induce immunoglobulin class-switch DNA recombination: relevance to microbial antibody responses.

Authors:  Egest J Pone; Hong Zan; Jingsong Zhang; Ahmed Al-Qahtani; Zhenming Xu; Paolo Casali
Journal:  Crit Rev Immunol       Date:  2010       Impact factor: 2.214

7.  Targeting Bruton's tyrosine kinase signaling as an emerging therapeutic agent of B-cell malignancies.

Authors:  Bing Xia; Fulian Qu; Tian Yuan; Yizhuo Zhang
Journal:  Oncol Lett       Date:  2015-10-13       Impact factor: 2.967

Review 8.  Advances in targeted therapy for malignant lymphoma.

Authors:  Li Wang; Wei Qin; Yu-Jia Huo; Xiao Li; Qing Shi; John E J Rasko; Anne Janin; Wei-Li Zhao
Journal:  Signal Transduct Target Ther       Date:  2020-03-06

9.  Myeloid-Derived Suppressor Cells Impair B Cell Responses in Lung Cancer through IL-7 and STAT5.

Authors:  Yong Wang; Cara C Schafer; Kenneth P Hough; Sultan Tousif; Steven R Duncan; John F Kearney; Selvarangan Ponnazhagan; Hui-Chen Hsu; Jessy S Deshane
Journal:  J Immunol       Date:  2018-05-11       Impact factor: 5.422

10.  Functional redundancy of Sos1 and Sos2 for lymphopoiesis and organismal homeostasis and survival.

Authors:  Fernando C Baltanás; Martín Pérez-Andrés; Alicia Ginel-Picardo; David Diaz; David Jimeno; Pilar Liceras-Boillos; Robert L Kortum; Lawrence E Samelson; Alberto Orfao; Eugenio Santos
Journal:  Mol Cell Biol       Date:  2013-09-16       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.